SGLT2 inhibitors and GLP1 agonists administered without metformin compared to other glucose‐lowering drugs in patients with type 2 diabetes mellitus to prevent cardiovascular events: A systematic review
Sign Up to like & getrecommendations! Published in 2020 at "Diabetic Medicine"
DOI: 10.1111/dme.14502
Abstract: To assess the efficacy of glucagon‐like peptide‐1 receptor agonists (GLP1‐RAs) and sodium‐glucose co‐transporter 2 (SGLT2) inhibitors, administered without metformin on cardiovascular outcomes in type 2 diabetes patients. read more here.
Keywords: sglt2 inhibitors; type diabetes; administered without; without metformin ... See more keywords
Bicalutamide with or without metformin for biochemical recurrence in prostate cancer patients (BIMET-1).
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.6_suppl.85
Abstract: 85Background: Metformin (MET) may play a role as an anti-proliferative and anti-carcinogenic agent. Epidemiological studies have demonstrated that MET is associated with decreased prostate cancer (... read more here.
Keywords: prostate; bicalutamide without; metformin biochemical; prostate cancer ... See more keywords